Saffron pre-treatment offers neuroprotection to nigral and retinal dopaminergic cells of MPTP-treated mice

Journal of Parkinson's Disease

Volumn 3, Issue 1, 2013, Pages 77-83

  Purushothuman, Sivaraman ^a   Nandasena, Charith ^a   Peoples, Cassandra L ^a   El Massri, Nabil ^a   Johnstone, Daniel M ^a   Mitrofanis, John ^a   Stone, Jonathan ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

amacrine cell; neuroprotection; Parkinson's disease; substantia nigra; Tyrosine hydroxylase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CROCUS SATIVUS EXTRACT; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL FRACTIONATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOPAMINERGIC NERVE CELL; IMMUNOCYTOCHEMISTRY; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA AMACRINE CELL; SUBSTANTIA NIGRA PARS COMPACTA;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CROCUS; DISEASE MODELS, ANIMAL; DOPAMINERGIC NEURONS; MALE; MICE; MICE, INBRED BALB C; MPTP POISONING; NEUROPROTECTIVE AGENTS; NEUROTOXINS; PARKINSON DISEASE; PHYTOTHERAPY; PLANT PREPARATIONS; RETINA; SUBSTANTIA NIGRA;

EID: 84880231514     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130173     Document Type: Article

References (23)

1. Schapira AH (2009) Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease. Neurology, 17, S44-S50.
2. Wallace BA, Ashkan K, Heise CE, Foote KD, Torres N, Mitrofanis J, & Benabid AL (2007) Survival of midbrain dopaminergic cells after lesion or deep brain stimulation of the subthalamic nucleus in MPTP-treated monkeys. Brain 130, 2129-45.
3. Shaw VE, Spana S, Ashkan K, Benabid AL, Stone J, Baker GE, & Mitrofanis J (2010) Neuroprotection of midbrain dopaminergic cells in MPTP-treated mice after near-infrared light treatment. J Comp Neurol 1518, 25-40.
4. Peoples C, Shaw VE, Jeffery G, Stone J, Baker GE, &Mitrofanis J (2012) Survival of dopaminergic amacrine cells after near-infrared light (NIr) treatment in MPTP-treated mice. ISRN Neurology, 850150
5. Maccarone R, Di Marco S, & Bisti S (2008) Saffron supplement maintains morphology and function after exposure to damaging light in mammalian retina. Invest Ophthalmol Vis Sci, 49, 1254-1261.
6. Natoli R, Zhu Y, Valter K, Bisti S, Eells J, & Stone J (2010) Gene and noncoding RNA regulation underlying photoreceptor protection: Microarray study of dietary antioxidant saffron and photobiomodulation in rat retina. Mol Vis 16, 1801-1822.
7. Falsini B, Piccardi M, Minnella A, Savastano C, Capoluongo E, Fadda A, Balestrazzi E, Maccarone R, & Bisti S (2010) Influence of saffron supplementation on retinal flicker sensitivity in early age-related macular degeneration. Invest Ophthalmol Vis Sci, 51, 6118-6124.
8. Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, Hong JW, & Lee EH (2010) Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol, 648, 110-116.
9. Hosseinzadeh H, Abootorabi A,&Sadeghnia HR (2008) Protective effect of Crocus sativus stigma extract and crocin (trans-crocin 4) on methyl methanesulfonate-induced DNA damage in mice organs. DNA Cell Biol, 27, 657-664.
10. Akhondzadeh S, Sabet MS, Harirchian MH, Togha M, Cheraghmakani H, Razeghi S, Hejazi SSh, Yousefi MH, Alimardani R, Jamshidi A, Zare F,&Moradi A (2010) Saffron in the treatment of patients with mild to moderate Alzheimer's disease: A 16-week, randomized and placebo-controlled trial. J Clinical Pharm Therap, 35, 581-588.
11. Piccardi M, Marangoni D, Minnella AM, Savastano MC, Valentini P, Ambrosio L, Capoluongo E, Maccarone R, Bisti S, & Falsini B (2012) A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: Sustained benefits to central retinal function. Evid Based Complement Alternat Med, 429124
12. Ahmad AS, Ansari MA, Ahmad M, Saleem S,Yousuf S, Hoda N, & Islam F (2005) Neuroprotection by crocetin in a hemiparkinsonian rat model. Pharm Biochem Behav, 81, 805-813.
13. Papandreou MA, Tsachaki M, Efthimiopoulos S, Cordopatis P, Lamari FN, & Margarity M (2011) Memory enhancing effects of saffron in aged mice are correlated with antioxidant protection. Behav Brain Res, 219, 197-204.
14. Ochiai T, Shimeno H, Mishima K, Iwasaki K, Fujiwara M, Tanaka H, Shoyama Y, Toda A, Eyanagi R, & Soeda S (2007) Protective effects of carotenoids from saffron on neuronal injury in vitro and in vivo. Biochim Biophys Acta, 1770, 578-584.
15. Mousavi SH, Tayarani NZ, & Parsaee H (2010) Protective effect of saffron extract and crocin on reactive oxygen speciesmediated high glucose-induced toxicity in PC12 cells. Cell Mol Neurobiol, 30, 185-191.
16. Bj̈orklund A, Rosenblad C, Winkler C, & Kirik D (1997) Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease. Neurobiol Dis 4, 186-200.
17. Pellegrini N, Serafini M, Salvatore S, Del Rio D, Bianchi M, & Brighenti F (2006) Total antioxidant capacity of spices, dried fruits, nuts, pulses, cereals and sweets consumed in Italy assessed by three different in vitro assays. Mol Nutr Food Res, 50, 1030-1038.
18. Przedborski S, Jackson-Lewis V, Djaldetti R, Liberatore G, Vila M, Vukosavic S, & Almer G (2000) The parkinsonian toxin MPTP: Action and mechanism. Restor Neurol Neurosci, 16, 135-142.
19. Ordoudi SA, Befani CD, Nenadis N, Koliakos GG, & Tsimidou MZ (2009) Further examination of antiradical properties of Crocus sativus stigmas extract rich in crocins. J Ag Food Chem, 57, 3080-3086.
20. Stone J, Johnstone D, & Mitrofanis J (2012) The helmet experiment in Parkinson's disease: An observation of the mechanism of neuroprotection by near infra-red light. Proceedings of WALT P928C0072.
21. Laabich A, Vissvesvaran G, Lieu K, Murata K, McGinn T, Manmoto C, Sinclair J, Karliga I, Leung D, Fawzi A, & Kubota R (2006) Protective Effect of Crocin against Blue Light-and White Light-Mediated Photoreceptor Cell Death in Bovine and Primate Retinal Primary Cell Culture. Invest Ophthalmol Vis Sci 47, 3156-3163.
22. Wang Y, Han T, Zhu Y, Zheng C, Ming J, Rahman QL, & Qin K, LP (2009) Antidepressant properties of bioactive fractions from the extract of Crocus sativus. J Nat Med, 64, 24-30.
23. Papandreou MA, Kanakis CD, Polissiou MG, Efthimiopoulos S, Cordopatis P, Margarity M, & Lamari FN (2006) Inhibitory activity on amyloid-beta aggregation and antioxidant properties of Crocus sativus stigmas extract and its crocin constituents. J Ag Food Chem, 54, 8762-8768.